In addition, 2 independent datasets from CRISPR- and RNAi-based screens (DepMap portal) revealed that nearly all prostate cancer cell lines were highly sensitive to MED12 downregulation, suggesting its pivotal role in prostate cancer cell growth and survival. Here, MED12 is linked to Familial prostate cancer.